These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
364 related items for PubMed ID: 27899639
1. Histone demethylase PHF8 promotes epithelial to mesenchymal transition and breast tumorigenesis. Shao P, Liu Q, Maina PK, Cui J, Bair TB, Li T, Umesalma S, Zhang W, Qi HH. Nucleic Acids Res; 2017 Feb 28; 45(4):1687-1702. PubMed ID: 27899639 [Abstract] [Full Text] [Related]
2. Histone demethylase PHF8 promotes cell growth and metastasis of non-small-cell lung cancer through activating Wnt/β-catenin signaling pathway. Hu Y, Mu H, Yang Y. Histol Histopathol; 2021 Aug 28; 36(8):869-877. PubMed ID: 34100557 [Abstract] [Full Text] [Related]
4. miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition. Yu Y, Luo W, Yang ZJ, Chi JR, Li YR, Ding Y, Ge J, Wang X, Cao XC. Mol Cancer; 2018 Mar 06; 17(1):70. PubMed ID: 29510731 [Abstract] [Full Text] [Related]
5. Histone demethylase PHF8 promotes prostate cancer metastasis via the E2F1-SNAI1 axis. Wang Z, Tang P, Xiao H, Peng S, Chen J, Wang Y, Xu J, Yan Q, Zhang J, Deng J, Ma Q, Zhu H, Luo W, Zhang D, Wang L, Qin J, Lan W, Jiang J, Liu Q. J Pathol; 2024 Sep 06; 264(1):68-79. PubMed ID: 39022843 [Abstract] [Full Text] [Related]
8. c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer. Maina PK, Shao P, Liu Q, Fazli L, Tyler S, Nasir M, Dong X, Qi HH. Oncotarget; 2016 Nov 15; 7(46):75585-75602. PubMed ID: 27689328 [Abstract] [Full Text] [Related]
9. Histone demethylase PHF8 regulates hypoxia signaling through HIF1α and H3K4me3. Maina PK, Shao P, Jia X, Liu Q, Umesalma S, Marin M, Long D, Concepción-Román S, Qi HH. Biochim Biophys Acta Gene Regul Mech; 2017 Sep 15; 1860(9):1002-1012. PubMed ID: 28734980 [Abstract] [Full Text] [Related]
10. Disrupting PHF8-TOPBP1 connection elicits a breast tumor-specific vulnerability to chemotherapeutics. Ma S, Zhang J, Guo Q, Cao C, Bao K, Liu L, Chen CD, Liu Z, Yang J, Yang N, Yao Z, Shi L. Cancer Lett; 2022 Apr 01; 530():29-44. PubMed ID: 35051531 [Abstract] [Full Text] [Related]
11. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Huang JY, Zhang K, Chen DQ, Chen J, Feng B, Song H, Chen Y, Zhu Z, Lu L, De W, Wang R, Chen LB. Oncotarget; 2015 Jul 30; 6(21):18613-30. PubMed ID: 26164082 [Abstract] [Full Text] [Related]
12. C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc/snail/Bax signaling. Lin X, Sun R, Zhao X, Zhu D, Zhao X, Gu Q, Dong X, Zhang D, Zhang Y, Li Y, Sun B. J Mol Med (Berl); 2017 Jan 30; 95(1):53-67. PubMed ID: 27543492 [Abstract] [Full Text] [Related]
13. Oncogenic features of PHF8 histone demethylase in esophageal squamous cell carcinoma. Sun X, Qiu JJ, Zhu S, Cao B, Sun L, Li S, Li P, Zhang S, Dong S. PLoS One; 2013 Jan 30; 8(10):e77353. PubMed ID: 24146981 [Abstract] [Full Text] [Related]
14. Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis. Wang Q, Ma S, Song N, Li X, Liu L, Yang S, Ding X, Shan L, Zhou X, Su D, Wang Y, Zhang Q, Liu X, Yu N, Zhang K, Shang Y, Yao Z, Shi L. J Clin Invest; 2016 Jun 01; 126(6):2205-20. PubMed ID: 27183383 [Abstract] [Full Text] [Related]
15. Transcriptional positive cofactor 4 promotes breast cancer proliferation and metastasis through c-Myc mediated Warburg effect. Luo P, Zhang C, Liao F, Chen L, Liu Z, Long L, Jiang Z, Wang Y, Wang Z, Liu Z, Miao H, Shi C. Cell Commun Signal; 2019 Apr 16; 17(1):36. PubMed ID: 30992017 [Abstract] [Full Text] [Related]
16. Histone H4K20/H3K9 demethylase PHF8 regulates zebrafish brain and craniofacial development. Qi HH, Sarkissian M, Hu GQ, Wang Z, Bhattacharjee A, Gordon DB, Gonzales M, Lan F, Ongusaha PP, Huarte M, Yaghi NK, Lim H, Garcia BA, Brizuela L, Zhao K, Roberts TM, Shi Y. Nature; 2010 Jul 22; 466(7305):503-7. PubMed ID: 20622853 [Abstract] [Full Text] [Related]
17. TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation. Drasin DJ, Guarnieri AL, Neelakantan D, Kim J, Cabrera JH, Wang CA, Zaberezhnyy V, Gasparini P, Cascione L, Huebner K, Tan AC, Ford HL. Cancer Res; 2015 May 01; 75(9):1908-21. PubMed ID: 25716682 [Abstract] [Full Text] [Related]
18. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer. Kong X, Ding X, Li X, Gao S, Yang Q. Cancer Sci; 2015 Aug 01; 106(8):982-9. PubMed ID: 26011542 [Abstract] [Full Text] [Related]
19. PHF8 is a histone H3K9me2 demethylase regulating rRNA synthesis. Zhu Z, Wang Y, Li X, Wang Y, Xu L, Wang X, Sun T, Dong X, Chen L, Mao H, Yu Y, Li J, Chen PA, Chen CD. Cell Res; 2010 Jul 01; 20(7):794-801. PubMed ID: 20531378 [Abstract] [Full Text] [Related]
20. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Smith AL, Iwanaga R, Drasin DJ, Micalizzi DS, Vartuli RL, Tan AC, Ford HL. Oncogene; 2012 Dec 13; 31(50):5162-71. PubMed ID: 22286770 [Abstract] [Full Text] [Related] Page: [Next] [New Search]